Your browser is no longer supported. Please, upgrade your browser.
WST [NYSE]
West Pharmaceutical Services, Inc.
IndexS&P 500 P/E59.73 EPS (ttm)6.84 Insider Own0.40% Shs Outstand74.00M Perf Week1.28%
Market Cap30.43B Forward P/E46.42 EPS next Y8.80 Insider Trans-3.82% Shs Float73.50M Perf Month-8.89%
Income519.20M PEG2.19 EPS next Q1.80 Inst Own96.20% Short Float1.19% Perf Quarter9.67%
Sales2.52B P/S12.06 EPS this Y42.50% Inst Trans0.27% Short Ratio2.67 Perf Half Y28.05%
Book/sh27.47 P/B14.88 EPS next Y7.22% ROA18.80% Target Price423.00 Perf Year39.94%
Cash/sh7.74 P/C52.82 EPS next 5Y27.30% ROE27.90% 52W Range253.85 - 475.35 Perf YTD44.27%
Dividend0.68 P/FCF130.11 EPS past 5Y28.70% ROI15.90% 52W High-14.02% Beta1.00
Dividend %0.17% Quick Ratio2.40 Sales past 5Y8.90% Gross Margin39.40% 52W Low61.01% ATR10.48
Employees9200 Current Ratio3.10 Sales Q/Q37.30% Oper. Margin23.90% RSI (14)38.76 Volatility1.73% 2.42%
OptionableYes Debt/Eq0.13 EPS Q/Q104.80% Profit Margin20.60% Rel Volume0.66 Prev Close404.81
ShortableYes LT Debt/Eq0.12 EarningsOct 28 BMO Payout9.50% Avg Volume328.18K Price408.72
Recom2.00 SMA20-3.63% SMA50-6.62% SMA20016.71% Volume216,369 Change0.97%
Nov-10-20Initiated KeyBanc Capital Markets Overweight $350
Oct-14-20Initiated Stephens Equal-Weight $300
Jul-21-20Upgrade BofA Securities Neutral → Buy $280
Apr-24-20Upgrade BofA/Merrill Underperform → Neutral $145 → $200
Dec-12-19Downgrade BofA/Merrill Neutral → Underperform
Jul-26-19Upgrade BofA/Merrill Underperform → Neutral
May-01-19Downgrade Jefferies Buy → Hold $122
Apr-23-19Initiated William Blair Outperform
Apr-25-18Downgrade BofA/Merrill Neutral → Underperform
Jan-24-18Initiated Goldman Neutral
Oct-17-17Downgrade BofA/Merrill Buy → Neutral
Oct-03-17Initiated Stephens Equal-Weight
Sep-15-17Upgrade Jefferies Hold → Buy
Oct-28-16Upgrade Wells Fargo Market Perform → Outperform
Sep-21-16Downgrade Wells Fargo Outperform → Market Perform
Mar-22-16Initiated Wells Fargo Outperform
May-14-10Reiterated UBS Neutral $41 → $44
Feb-23-10Initiated Jefferies & Co Buy $45
Dec-19-08Initiated UBS Neutral $41
Dec-19-08Initiated UBS Neutral
Oct-18-21 11:35AM  
Oct-14-21 06:00AM  
Oct-12-21 12:10PM  
Oct-07-21 12:04PM  
Oct-06-21 11:50AM  
Oct-05-21 10:29AM  
Sep-29-21 12:43PM  
11:07AM  
Sep-28-21 08:54AM  
06:48AM  
Sep-27-21 07:32AM  
Sep-23-21 08:41AM  
Sep-22-21 10:06AM  
Sep-17-21 07:14AM  
Sep-16-21 09:09AM  
Sep-15-21 10:27AM  
Sep-10-21 12:45PM  
Sep-09-21 08:21AM  
Sep-06-21 01:10PM  
12:00PM  
10:30AM  
09:15AM  
Sep-03-21 09:52AM  
Sep-02-21 09:08AM  
08:24AM  
Aug-30-21 02:43PM  
10:31AM  
Aug-27-21 08:17AM  
Aug-26-21 09:34AM  
08:52AM  
Aug-25-21 12:45PM  
10:06AM  
Aug-24-21 09:05AM  
Aug-23-21 04:30PM  
07:58AM  
Aug-18-21 01:20PM  
10:58AM  
09:34AM  
Aug-16-21 12:00PM  
Aug-13-21 05:35AM  
Aug-12-21 09:57AM  
Aug-11-21 09:01AM  
Aug-10-21 09:57AM  
Aug-09-21 01:00PM  
11:05AM  
09:01AM  
Aug-06-21 01:02PM  
12:39PM  
12:13PM  
10:07AM  
08:40AM  
08:36AM  
08:19AM  
08:14AM  
Aug-05-21 12:45PM  
12:20PM  
12:00PM  
11:54AM  
10:31AM  
08:21AM  
08:03AM  
07:22AM  
07:20AM  
Aug-04-21 01:12PM  
11:26AM  
10:12AM  
09:34AM  
09:19AM  
08:53AM  
Aug-03-21 12:20PM  
Aug-02-21 09:54AM  
07:15AM  
Jul-30-21 12:49PM  
12:35PM  
11:54AM  
10:33AM  
10:28AM  
10:24AM  
10:22AM  
09:55AM  
09:41AM  
09:13AM  
09:11AM  
09:09AM  
Jul-29-21 02:00PM  
08:35AM  
07:45AM  
06:00AM  
Jul-26-21 08:33AM  
Jul-15-21 03:01PM  
06:00AM  
Jul-13-21 10:15AM  
Jul-09-21 07:16AM  
Jul-06-21 09:51AM  
09:19AM  
08:27AM  
Jun-30-21 04:56PM  
12:02PM  
Jun-23-21 09:44AM  
09:41AM  
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lai Quintin JVP Corp Development & StrategySep 10Option Exercise61.029,672590,16811,906Sep 14 10:45 AM
Lai Quintin JVP Corp Development & StrategySep 10Sale460.769,6724,456,4522,234Sep 14 10:45 AM
Abraham SiljiChief Digital & Trans OfficerMay 10Sale335.002,171727,2856,077May 10 04:49 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.Nov 06Option Exercise62.309,000560,70016,540Nov 09 06:36 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.Nov 06Sale296.679,0002,670,0417,540Nov 09 06:36 PM